Biscrotec Injection (Sodium Hyaluronate) (Pre-filled)

Adult administration

1. Cataract surgery and intraocular lens implantation: Slowly inject into the anterior chamber of the eye before or after lens removal. Injection should be performed before cataract extraction or insertion of the intraocular lens to optimize the supportive effects on corneal endothelial protection. 2. Corneal transplant surgery: After removing the corneal graft, fill the anterior chamber with this medication until the corneal surface and fluid level match, then place the donor graft and suture it. 3. Glaucoma filtration surgery: Inject this medication through corneal puncture during trabeculectomy to supplement and maintain anterior chamber volume.

This medication contains sodium hyaluronate and is primarily used for ophthalmic applications after eye surgery. This medication should not be used in patients who have had allergic reactions to protein-based drugs. Caution is necessary when using this drug, as side effects such as increased intraocular pressure, inflammation, corneal edema, and vision disturbances may occur. Moreover, intraocular pressure should be carefully measured immediately after eye surgery, and if the pressure rises, appropriate treatment should be administered. After surgery, it is advisable to wash or aspirate this medication from inside the eye, and during surgery, appropriate irrigation solutions should be used to prevent the drug from coming into direct contact with the eye tissues. Care should be taken to avoid contact with specific cleansers or disinfectants, such as benzalkonium chloride, as mixing with such substances can cause precipitation. This medication may cause immune reactions or other risks, so care is required during administration. It should not be used in conjunction with other medications like hyaluronidase. This medication is for ophthalmic use only and must never be injected intravascularly. Before use, allow the refrigerated drug to sit at room temperature for about 30 minutes to adjust the temperature, and once opened, it should be used only once, discarding any leftover medication. During injection, care should be taken to ensure that air does not enter the eye, and excessive administration may lead to elevated intraocular pressure and other issues. This medication should be stored out of the reach of children, protected from direct sunlight, and kept in a cool, dry place. Additionally, it is important not to transfer it to other containers to maintain quality.

Mild side effects

Increased intraocular pressure, inflammatory reactions, corneal edema, corneal opacity, anterior hemorrhage, iris neovascularization, posterior ulcers of the iris, conjunctival adhesions, mydriasis, lens opacity, pain, pruritus, blurred vision, corneal disability, opacification of the surface of the intraocular lens, corneal calcification

This medication should be stored in a sealed container at a cool temperature between 2 to 8 degrees Celsius. Protect from direct sunlight and ensure it does not freeze.

Appearance

A colorless, transparent, and viscous liquid contained in a glass vial sealed with rubber stoppers (part of the pre-filled syringe system)

Package unit

0.85mL/vial